Drug shortages are a significant public health issue in the United States, and addressing shortages remains a top priority for FDA. Establishment of clear procedures and guidelines for managing drug shortages is essential to overcome this issue. FDA has given this Strategic Plan to address drug shortages in the United States. Recently the President and Congress have taken important actions which enabled FDA to learn more about possible shortages before they occur. These actions have helped FDA to prevent 78 shortages in the first three quarters of 2014. This Strategic Plan is consisting of three sections. The first section is about knowing the causes of shortages, and describing current efforts by FDA’s to resolve existing shortages and
